Table 5 Topics reported as being "very important" or "quite important" for the National Ethics Committees (NECs).
From: Capacity mapping of national ethics committees in the Eastern Mediterranean Region
Topics | Numbers of NECs reporting topic (%) |
|---|---|
Monitoring and oversight | 87% (13/15) |
Assessment of understanding of informed consent | 80% (12/15) |
Privacy and confidentiality | 80% (12/15) |
Provision of appropriate risk reduction measures | 80% (12/15) |
Assessment of cultural sensitivity for informed consent | 73% (11/15) |
Placebo controlled trials | 73% (11/15) |
Determination of appropriate subject selection in vulnerable populations | 67% (10/15) |
Assessment of anticipated benefits | 67% (10/15) |
Community participation | 67% (10/15) |
Determinations to conduct Phase I, II, and III clinical trials in a country or community | 60% (9/15) |
Incentives for participation | 60% (9/15) |